{"nct_id":"NCT00875264","title":"Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer","status":"COMPLETED","status_verified_date":"2012-07","start_date":"2007-09","start_date_type":null,"primary_completion_date":"2011-06","primary_completion_date_type":"ACTUAL","completion_date":"2011-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TEVA"]}